vs
ASP Isotopes Inc.（ASPI）与LIFECORE BIOMEDICAL, INC. \DE\（LFCR）财务数据对比。点击上方公司名可切换其他公司
LIFECORE BIOMEDICAL, INC. \DE\的季度营收约是ASP Isotopes Inc.的1.9倍（$31.1M vs $16.7M），ASP Isotopes Inc.同比增速更快（1295.7% vs -4.5%），LIFECORE BIOMEDICAL, INC. \DE\自由现金流更多（$25.0K vs $-47.4M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
LIFECORE BIOMEDICAL, INC.是一家生物医药企业，专注于研发和生产以透明质酸为主的高品质生物材料，业务覆盖医疗应用产品、制药解决方案、个人护理原料三大核心板块，主要市场遍布北美、欧洲、亚太地区，服务头部医疗器械、制药、美妆品牌客户。
ASPI vs LFCR — 直观对比
营收规模更大
LFCR
是对方的1.9倍
$16.7M
营收增速更快
ASPI
高出1300.1%
-4.5%
自由现金流更多
LFCR
多$47.5M
$-47.4M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $31.1M |
| 净利润 | — | $-10.0M |
| 毛利率 | 12.5% | 25.0% |
| 营业利润率 | — | -9.9% |
| 净利率 | — | -32.1% |
| 营收同比 | 1295.7% | -4.5% |
| 净利润同比 | -586.8% | -52.0% |
| 每股收益（稀释后） | — | $-0.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPILFCR
| Q4 25 | $16.7M | — | ||
| Q3 25 | $4.9M | $31.1M | ||
| Q1 25 | — | $35.2M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | — | $24.7M | ||
| Q1 24 | — | $35.7M | ||
| Q4 23 | — | $30.1M | ||
| Q3 23 | — | $24.5M |
净利润ASPILFCR
| Q4 25 | — | — | ||
| Q3 25 | $-12.9M | $-10.0M | ||
| Q1 25 | — | $-14.8M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | — | $-16.2M | ||
| Q1 24 | — | $15.6M | ||
| Q4 23 | — | $14.2M | ||
| Q3 23 | — | $-10.8M |
毛利率ASPILFCR
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | 25.0% | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q1 24 | — | 33.3% | ||
| Q4 23 | — | 33.0% | ||
| Q3 23 | — | 11.1% |
营业利润率ASPILFCR
| Q4 25 | — | — | ||
| Q3 25 | -306.1% | -9.9% | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | — | -46.9% | ||
| Q1 24 | — | -2.5% | ||
| Q4 23 | — | -4.9% | ||
| Q3 23 | — | -35.1% |
净利率ASPILFCR
| Q4 25 | — | — | ||
| Q3 25 | -263.7% | -32.1% | ||
| Q1 25 | — | -42.0% | ||
| Q4 24 | — | -20.2% | ||
| Q3 24 | — | -65.7% | ||
| Q1 24 | — | 43.8% | ||
| Q4 23 | — | 47.2% | ||
| Q3 23 | — | -43.9% |
每股收益（稀释后）ASPILFCR
| Q4 25 | — | — | ||
| Q3 25 | $-0.15 | $-0.29 | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | — | $-0.53 | ||
| Q1 24 | — | $0.42 | ||
| Q4 23 | — | $0.39 | ||
| Q3 23 | — | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $18.9M |
| 总债务越低越好 | $14.4M | $136.0M |
| 股东权益账面价值 | $204.2M | $-10.5M |
| 总资产 | $498.0M | $235.2M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPILFCR
| Q4 25 | $333.3M | — | ||
| Q3 25 | $113.9M | $18.9M | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
总债务ASPILFCR
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | $136.0M | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q1 24 | — | $97.1M | ||
| Q4 23 | — | $92.9M | ||
| Q3 23 | — | $88.8M |
股东权益ASPILFCR
| Q4 25 | $204.2M | — | ||
| Q3 25 | $74.1M | $-10.5M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $15.4M | ||
| Q3 24 | — | $-3.9M | ||
| Q1 24 | — | $17.7M | ||
| Q4 23 | — | $1.4M | ||
| Q3 23 | — | $-13.6M |
总资产ASPILFCR
| Q4 25 | $498.0M | — | ||
| Q3 25 | $225.9M | $235.2M | ||
| Q1 25 | — | $237.7M | ||
| Q4 24 | — | $255.4M | ||
| Q3 24 | — | $246.8M | ||
| Q1 24 | — | $246.2M | ||
| Q4 23 | — | $245.8M | ||
| Q3 23 | — | $245.6M |
负债/权益比ASPILFCR
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q1 24 | — | 5.49× | ||
| Q4 23 | — | 65.35× | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $1.8M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $25.0K |
| 自由现金流率自由现金流/营收 | -284.7% | 0.1% |
| 资本支出强度资本支出/营收 | 57.9% | 5.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-16.8M |
8季度趋势，按日历期对齐
经营现金流ASPILFCR
| Q4 25 | $-37.8M | — | ||
| Q3 25 | $-8.9M | $1.8M | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | — | $-6.1M | ||
| Q3 24 | — | $-613.0K | ||
| Q1 24 | — | $-1.4M | ||
| Q4 23 | — | $1.3M | ||
| Q3 23 | — | $-8.3M |
自由现金流ASPILFCR
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | $25.0K | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q1 24 | — | $-7.8M | ||
| Q4 23 | — | $-3.0M | ||
| Q3 23 | — | $-13.4M |
自由现金流率ASPILFCR
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | 0.1% | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q1 24 | — | -21.8% | ||
| Q4 23 | — | -9.9% | ||
| Q3 23 | — | -54.6% |
资本支出强度ASPILFCR
| Q4 25 | 57.9% | — | ||
| Q3 25 | 64.4% | 5.6% | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q1 24 | — | 17.8% | ||
| Q4 23 | — | 14.1% | ||
| Q3 23 | — | 20.6% |
现金转化率ASPILFCR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | -0.09× | ||
| Q4 23 | — | 0.09× | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPI
暂无分部数据
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
